Greg teaches Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Chief Innovation Officer at ICON plc, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He is co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained in neurosurgery at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on several healthcare company boards and medical advisory boards. Greg writes about innovation for Forbes.
